دورية أكاديمية
أعرض في EDS

Long-term observation of V4c implantable collamer lenses implantation for moderate to extreme high myopia correction: five years follow-up.

التفاصيل البيبلوغرافية
العنوان: Long-term observation of V4c implantable collamer lenses implantation for moderate to extreme high myopia correction: five years follow-up.
المؤلفون: Wan Q; Department of Ophthalmology, West China Hospital of Sichuan University, Chengdu, Sichuan, China., He P; Department of Ophthalmology, West China Hospital of Sichuan University, Chengdu, Sichuan, China.; Department of Health Management & Institute of Health Management, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, Sichuan, China., Wei R; Department of Ophthalmology, West China Hospital of Sichuan University, Chengdu, Sichuan, China., Ma K; Department of Ophthalmology, West China Hospital of Sichuan University, Chengdu, Sichuan, China. drmake@scu.edu.cn., Yin H; Department of Ophthalmology, West China Hospital of Sichuan University, Chengdu, Sichuan, China., Tang J; Department of Ophthalmology, West China Hospital of Sichuan University, Chengdu, Sichuan, China., Deng YP; Department of Ophthalmology, West China Hospital of Sichuan University, Chengdu, Sichuan, China. dyp_wch@163.com.
المصدر: Eye (London, England) [Eye (Lond)] 2024 Jul; Vol. 38 (10), pp. 1933-1940. Date of Electronic Publication: 2024 Mar 22.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8703986 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5454 (Electronic) Linking ISSN: 0950222X NLM ISO Abbreviation: Eye (Lond) Subsets: MEDLINE
أسماء مطبوعة: Publication: <2003->: London : Nature Publishing Group
Original Publication: [London : Ophthalmological Society of the United Kingdom, 1987-
مواضيع طبية MeSH: Visual Acuity*/physiology , Phakic Intraocular Lenses* , Lens Implantation, Intraocular*/methods , Intraocular Pressure*/physiology , Refraction, Ocular*/physiology , Myopia, Degenerative*/surgery , Myopia, Degenerative*/physiopathology, Humans ; Male ; Female ; Adult ; Follow-Up Studies ; Retrospective Studies ; Young Adult ; Treatment Outcome ; Axial Length, Eye/pathology ; Middle Aged ; Myopia/surgery ; Myopia/physiopathology
مستخلص: Background: This study aims to assess the long term effectiveness, safety, predictability and stability of V4c implantable collamer lenses (ICL) for correction of moderate to extreme high myopia.
Methods: We reviewed 125 eyes from 64 patients who implanted V4c ICL at the Refractive Surgery Center of West China Hospital in Chengdu, China, between May 2015 and January 2017. The median spherical equivalent was -11.50 D (interquartile range [IQR]: -13.00 to -9.00 D). We followed up with the patients over five years and evaluated several parameters, including uncorrected visual acuity (UDVA), corrected visual acuity (CDVA), axial length, refractive error, endothelial cell density (ECD), intraocular pressure (IOP), white-to-white distance (WTW), and vault. We performed a correlation analysis to explore the potential impacts on vault following implantation.
Results: The median safety index (postoperative CDVA/preoperative CDVA) during the last follow-up was 1.00 (interquartile range [IQR]: 1.00-1.20), and the efficacy indices (postoperative UDVA/preoperative CDVA) were 1.20 (IQR: 1.00-1.25), 1.20 (IQR: 1.00-1.33), and 0.8 (IQR: 0.65-1.00) at postoperative 1 week, 1 month, and 5 years, respectively. At the five-year mark, 16% of the eyes were within ±0.50 D of expected correction, and 73% were within ±2.00 D. No significant difference in ECD was observed between pre-operative and post-operative measurements. Compared to baseline, we observed a significant increase in IOP at the one-week follow-up, which decreased significantly at the one-month visit. Furthermore, we identified ICL size and spherical equivalent (SE) as independent variables in a multiple linear regression model that accurately predicted the five-year vault after surgery.
Conclusion: In conclusion, V4c ICL implantation is an effective and safe treatment for moderate to extreme high myopia with good predictability and stability over the long-term.
(© 2024. The Author(s), under exclusive licence to The Royal College of Ophthalmologists.)
References: Clin Ophthalmol. 2016 Jun 09;10:1059-77. (PMID: 27354760)
J Refract Surg. 2018 Nov 1;34(11):726-735. (PMID: 30428092)
Ophthalmol Ther. 2021 Dec;10(4):753-776. (PMID: 34417707)
Clin Exp Ophthalmol. 2016 Aug;44(6):481-7. (PMID: 26661832)
Br J Ophthalmol. 2020 May;104(5):600-603. (PMID: 31409648)
Graefes Arch Clin Exp Ophthalmol. 2012 Jun;250(6):935-9. (PMID: 22042291)
J Refract Surg. 2015 Aug;31(8):548-56. (PMID: 26248348)
Am J Ophthalmol. 2014 Mar;157(3):532-9.e1. (PMID: 24239774)
Exp Eye Res. 2021 Apr;205:108477. (PMID: 33516763)
Eye (Lond). 2021 Feb;35(2):362-382. (PMID: 32709958)
J Ophthalmol. 2018 Jun 19;2018:1329874. (PMID: 30018818)
JAMA Ophthalmol. 2021 Oct 01;139(10):1096-1103. (PMID: 34436537)
Eur J Ophthalmol. 2021 Apr 22;:11206721211012861. (PMID: 33887990)
Curr Eye Res. 2022 Apr;47(4):540-546. (PMID: 34894946)
Invest Ophthalmol Vis Sci. 2019 Jul 1;60(8):2781-2786. (PMID: 31260519)
J Cataract Refract Surg. 2013 Jun;39(6):915-21. (PMID: 23688878)
Zhonghua Yan Ke Za Zhi. 2023 Feb 11;59(2):129-134. (PMID: 36740442)
J Refract Surg. 2019 Mar 1;35(3):169-176. (PMID: 30855094)
Medicine (Baltimore). 2016 Apr;95(14):e3270. (PMID: 27057883)
Clin Ophthalmol. 2020 Oct 30;14:3681-3689. (PMID: 33162752)
Prog Retin Eye Res. 2018 Jan;62:134-149. (PMID: 28951126)
Am J Ophthalmol. 2014 Jun;157(6):1136-43. (PMID: 24503407)
Br J Ophthalmol. 2012 Mar;96(3):409-12. (PMID: 21733922)
Lancet. 2019 May 18;393(10185):2085-2098. (PMID: 31106754)
Acta Ophthalmol. 2012 Dec;90(8):788-91. (PMID: 21834924)
Br J Ophthalmol. 2018 Apr;102(4):544-548. (PMID: 28729370)
Am J Ophthalmol. 2017 Jun;178:65-78. (PMID: 28336402)
Br J Ophthalmol. 2022 Nov;106(11):1508-1513. (PMID: 34183326)
Clin Exp Optom. 2012 Jul;95(4):386-98. (PMID: 22672114)
Asia Pac J Ophthalmol (Phila). 2016 Nov/Dec;5(6):394-402. (PMID: 27898442)
Acta Ophthalmol. 2021 May;99(3):e288-e301. (PMID: 32841517)
Exp Eye Res. 2020 Sep;198:108136. (PMID: 32653492)
J Cataract Refract Surg. 2016 Jul;42(7):1078-93. (PMID: 27492109)
J Cataract Refract Surg. 2015 Aug;41(8):1610-5. (PMID: 26432117)
Acta Ophthalmol. 2021 Sep;99(6):e852-e859. (PMID: 33369209)
Eye (Lond). 2010 Apr;24(4):588-94. (PMID: 19590517)
تواريخ الأحداث: Date Created: 20240323 Date Completed: 20240705 Latest Revision: 20240708
رمز التحديث: 20240708
مُعرف محوري في PubMed: PMC11226664
DOI: 10.1038/s41433-024-03046-9
PMID: 38519715
قاعدة البيانات: MEDLINE
الوصف
تدمد:1476-5454
DOI:10.1038/s41433-024-03046-9